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OBJECTIVES This study was conducted to evaluate: 1) the effect of adjunctive percutaneous transluminal coronary
angioplasty (PTCA) after directional coronary atherectomy (DCA) compared with stand-alone DCA,
and 2) the outcome of intravascular ultrasound (IVUS)-guided aggressive DCA.
BACKGROUND It has been shown that optimal angiographic results after coronary interventions are associated with a
lower incidence of restenosis. Adjunctive PTCA after DCA improves the acute angiographic outcome;
however, long-term benefits of adjunctive PTCA have not been established.
METHODS Out of 225 patients who underwent IVUS-guided DCA, angiographically optimal debulking was
achieved in 214 patients, then they were randomized to either no further treatment or to added PTCA.
RESULTS Postprocedural quantitative angiographic analysis demonstrated an improved minimum
luminal diameter (2.88 6 0.48 vs. 2.6 6 0.51 mm; p 5 0.006) and a less residual stenosis
(10.8% vs.15%; p 5 0.009) in the adjunctive PTCA group. Quantitative ultrasound analysis
showed a larger minimum luminal diameter (3.26 6 0.48 vs. 3.04 6 0.5 mm; p , 0.001) and
lower residual plaque mass in the adjunctive PTCA group (42.6% vs. 45.6%; p , 0.001).
Despite the improved acute findings in the adjunctive PTCA group, six-month angiographic
and clinical results were not different. The restenosis rate (adjunctive PTCA 23.6%, DCA
alone 19.6%; p 5 ns) and target lesion revascularization rate (20.6% vs. 15.2%; p 5 ns) did
not differ between the groups.
CONCLUSIONS With IVUS guidance, aggressive DCA can safely achieve optimal angiographic results with low
residual plaque mass, and this was associated with a low restenosis rate. Although adjunctive PTCA
after optimal DCA improved the acute quantitative coronary angiography and quantitative coronary
ultrasonography outcomes, its benefit was not maintained at six months. (J Am Coll Cardiol 1999;34:
1028–35) © 1999 by the American College of Cardiology
Directional coronary atherectomy (DCA) was introduced to
improve the acute outcome of coronary interventions as well
as to reduce restenosis by debulking atheromatous tissue (1).
Coronary Angioplasty Versus Excisional Atherectomy Trial
(CAVEAT) (2), the first randomized trial to compare DCA
and percutaneous transluminal coronary angioplasty
(PTCA), failed to demonstrate a significant reduction in
restenosis. It was thought that one of the reasons for the
relatively high restenosis rate among DCA patients was due
to the performance of less than optimal DCA procedures.
There are two approaches to achieve an optimal initial
DCA outcome: more aggressive debulking and post-DCA
adjunctive balloon dilations. The Optimal Atherectomy
Restenosis Study (OARS) demonstrated that optimal DCA
followed by adjunctive PTCA resulted in a minimal residual
stenosis with a relatively low restenosis rate (3). Balloon
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Versus Optimal Atherectomy Trial (BOAT), a recent
randomized trial, demonstrated that the restenosis rate is
significantly lower after “optimal DCA,” usually in conjunc-
tion with adjunctive dilation, compared with PTCA (4). In
the OARS trial, despite “optimal DCA” by angiographic
criteria, the residual plaque area assessed by intravascular
ultrasound (IVUS) was significantly high. Some preliminary
reports suggest that plaque burden is an important predictor
for restenosis, thus more aggressive plaque removal may be
required for further reduction of the restenosis rate. By
using IVUS-derived information before or during DCA to
guide the procedure, more effective debulking may be
possible to achieve less plaque burden (5). Adjunctive
PTCA seems to improve lumen size further after “optimal”
DCA; however, there is no information available regarding
the acute as well as long-term effect of adjunctive PTCA
after more aggressive IVUS-guided DCA.
The purpose of this study is to evaluate: 1) the effect of
adjunctive PTCA after DCA compared with stand-alone
DCA, and 2) the outcome of IVUS-guided aggressive
DCA.
METHODS
This was a prospective multicenter randomized trial to
evaluate the effect of balloon dilation after optimal DCA.
The study was performed between December 1994 and
September 1995.
Study site and operators. The trial was conducted at 12
institutions in Japan. These institutions had been well
experienced in DCA procedures and other complex inter-
ventional therapy. To maintain the quality level of the
procedure, individual operators had to have performed over
50 DCA procedures to be qualified for this study.
Patient selection. Patients were selected according to the
following inclusion and exclusion criteria.
1. Inclusion criteria:
c symptomatic coronary artery disease
c native coronary artery
c de novo lesion or restenotic lesion (from one prior
PTCA)
c lesion stenosis ^75% and ,100% and %15 mm in length
by visual estimation
c vessel suitable for DCA device size ^7 F
c acceptable candidate for coronary artery bypass graft
(CABG)
c age between 20 and 80-years-old
c signed written informed consent
2. Exclusion criteria:
c culprit lesion for acute myocardial infarction within the
last one month
c left main lesion/right coronary artery ostial lesion
c angulated lesion .60°
c diffuse disease
c presence of thrombus at the lesion
c significant tortuosity
c severe peripheral vascular disease
c markedly calcified lesion by angiography and/or superfi-
cial calcium .180° detected by IVUS and concomitant
significant medical condition.
Initial patient enrollment and DCA procedure. Consec-
utive patients who were treated with coronary intervention
and who met the clinical and angiographic criteria were
enrolled into the trial after informed consent was obtained
under a protocol approved by the Institutional Review
Board at each participating center. The patients then
underwent IVUS evaluation. Patients with greater than 180°
of superficial calcification were eliminated and deregistered
from this study. The initial IVUS information was used for
device selection and window orientation based on plaque
distribution. DCA was performed using the Simpson Cor-
onary AtheroCath (Guidant, Santa Clara, California).
DCA was performed in a routine fashion, typically starting
with low balloon pressures (5 to 10 psi). Multiple cuts were
obtained using gradually increasing balloon pressures. The
goal of optimal DCA by angiographic appearance was a
,30% angiographic residual stenosis by visual estimation,
and operators felt that no further treatment was necessary
based on the angiographic findings. After achievement of
angiographically optimal DCA, IVUS was repeated to
evaluate the residual plaque burden. When visual estimation
of residual plaque was felt to be significant and atherectomy
was inadequate, DCA was repeated with a more aggressive
approach based on IVUS information; precise orientation of
the window towards the plaque using higher balloon pres-
sures and making multiple cuts was generally recommended.
After each device insertion, the results were evaluated by
both angiography and IVUS. If the debulking still appeared
to be inadequate, the procedure was again repeated. When
the operator achieved an optimal DCA outcome by angio-
graphic criteria (visually estimated residual stenosis ,30%)
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or by IVUS findings with adequate debulking (visually
estimated percent plaque area ,50%), or felt that no further
debulking could be achieved despite significant residual
plaque, the DCA procedure was completed.
Randomization and adjunctive balloon dilation. The
criteria for successful DCA for randomization was based on
angiographic information. Patients with a residual stenosis
of less than 30% by visual estimation without significant
angiographic complications were randomized to either
DCA treatment alone (no further therapy) or DCA with
adjunctive PTCA. Those patients who could not reach
those criteria or who had procedural complications during
the initial DCA were excluded from randomization and
were treated accordingly by physician’s preference. The
balloon catheters used for the adjunctive dilation were
selected based on visual estimation of the vessel size with a
balloon/artery ratio of 1.1 to 1.3, and balloon inflations for
3 min at low pressures (2 to 5 atmospheres) were recom-
mended.
Angiography and IVUS. Coronary angiography was per-
formed after administration of 100 to 200 mg of nitroglyc-
erin before the procedure. Angiograms were taken in two
orthogonal views. The angles of these views were recorded.
After DCA and PTCA, angiograms were repeated in the
same angles. For the IVUS procedures, 2.9 F or 3.2 F CVIS
catheters were used. After placing the IVUS catheter distal
to the target lesion, intracoronary nitroglycerin was admin-
istered. The catheter was slowly pulled back either manually
or using the automatic pullback system, and images were
recorded in VTR. Images obtained during the procedure
were used for case selection and procedure guidance.
Quantitative analysis. Angiograms were analyzed by ex-
perienced angiographers at the angiographic core lab at
Stanford University Medical Center. The analysis was
performed blindly for the treatment arm. Pre- and postan-
giographic lesion morphology was analyzed using American
Heart Association classification. The view that showed the
most significant stenosis was used for quantitative coronary
angiographic (QCA) analysis. QCA was performed using
Stanford’s method, which utilizes the validated edge-
detection algorithm. Reference vessel size, minimum lumen
diameter (MLD) and diameter stenosis (DS) were mea-
sured. Quantitative coronary ultrasonography (QCU) anal-
ysis was performed at independent core lab by experienced
physicians for IVUS at Stanford University. The lumen/
atheroma border and external elastic membrane (EEM)
were traced manually. From these tracings, vessel area,
lumen area, plaque area and MLD values were automatically
measured by computer.
Core pathology laboratory. Gifu University Hospital
served as the core pathology laboratory. Tissue samples were
weighed and fixed with a 4% formaldehyde solution. Tissue
was stained using hematoxylin-eosin and elastic van Gieson,
and were analyzed by trained pathologists using an optical
microscope.
Follow-up information. Patients were followed by inves-
tigators at each center. If patients had recurrent ischemic
symptoms, they were treated as needed. Patients returned to
the investigational centers for clinical and angiographic
evaluation at three and six months. Angiograms were
obtained after intracoronary nitroglycerin, using the same
orthogonal views as before. When a patient had angio-
graphic evidence of restenosis at three or six months, the
decision whether to perform a repeat interventional proce-
dure or not depended on the patient’s condition, as well as
the preference of the investigator.
Study end points. The primary end point of this study was
the angiographic restenosis rate at six months, defined as
.50% stenosis by angiography, comparing the group with
optimal DCA and the group with optimal DCA followed
by PTCA. In addition, QCA and QCU measurements were
compared between the two groups. The secondary end point
was the clinical event rate (death, myocardial infarction,
target vessel revascularization) at six months among these
two groups.
Data management and statistical analysis. Investigators
at each institution obtained clinical and procedural data as
well as follow-up data. The clinical data and QCA and
QCU data were collected at Quintils Asia, Inc. (Tokyo,
Japan). The size of required sample (200 patients) was based
on the assumed rate of angiographic restenosis of 32% in the
DCA alone group and 15% in the adjunctive PTCA group
(by a two-sided test with an alpha error of 0.05 and a power
of 0.80). To compensate for unsuccessful intervention pro-
cedures and losses to follow-up, the sample was enlarged by
10% (to 220 patients). For the analysis of continuous data,
Wilcoxon test was used to assess differences between the
two groups and the results are expressed as means 6 SD.
Categorical data, which are presented as rates, were com-
pared by chi-square test. For the follow-up clinical data,
Wilcoxon test was used for the comparison between the two
groups.
RESULTS
In total, 239 patients were initially enrolled in this study
based on clinical and angiographic criteria (Fig. 1). Of
these, 14 patients were eliminated for the following reasons:
12 patients with calcification greater than 180° by IVUS and
two patients with no IVUS image due to equipment
malfunction. Thus, 225 patients were enrolled in this study
and underwent DCA. Of these, 11 patients were excluded
from randomization; complications requiring further treat-
ment occurred in six patients (dissection in four patients,
distal embolism in one patient and an aneurysm in one
patient), a less than optimal result requiring further treat-
ment in four patients and failure to cross with a DCA device
in one patient. These patients were subsequently treated
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with PTCA (five patients) or stents (six patients). There-
fore, the overall success rate achieving angiographic optimal
DCA was 95.1%. Overall interventional procedure success
rate without significant major complication was 99.5%.
None required CABG. There were no deaths, and one
patient (0.5%) suffered a Q wave myocardial infarction.
Subsequently, a total of 214 cases with successful DCA were
randomized into two groups: 106 patients in the DCA
alone group and 108 patients in the adjunctive PTCA after
DCA group. An example of a case is shown in Figure 2.
Patient and lesion characteristics. Patient characteristics
for each group are summarized in Table 1. Despite random-
ization, males and hypertension were more frequently ob-
served in the DCA alone group. Although there was a trend
for more unstable angina in the DCA alone group, these
differences were not statistically significant. Target vessel
and lesion characteristics are summarized in Table 2. The
majority of lesions were de novo, and more than half of the
target vessels were LAD. Approximately 80% of the lesions
were type B, and none of them were type C. There were no
significant differences in lesion characteristics among these
two groups.
Procedure information. None of the lesions were predi-
lated with a balloon before DCA. DCA procedure results
are summarized in Table 3. There were no significant
procedural differences between these two groups. All pa-
tients were treated with either a 7 F device or a 7 F graft
device. In approximately one-third of the patients, DCA
was repeated after initial post-DCA IVUS evaluation (two
cycles or more). Among adjunctive balloon dilation in the
randomized group, mean balloon/artery ratio was 1.2, mean
balloon inflation pressure was 6 atmospheres and mean
duration was 312 s.
Use of IVUS information for DCA. After each cycle of
DCA, IVUS information was obtained and used to decide
if further treatment with DCA was needed or not. After
initial angiographically optimal DCA, repeat IVUS was
performed, and in 62% of patients, DCA was completed
(one cycle). Twenty-eight percent of patients underwent a
second-cycle DCA procedure after IVUS evaluation, and
10% of patients had three or more cycles of DCA. The
relationship between the number of cycles of DCA treat-
ment and procedural factors is summarized in Table 4. The
total number of cuts increased with DCA treatment cycles.
Figure 1. Patient treatment algorithm. (CAG 5 coronary angio-
gram; DCA 5 directional coronary atherectomy).
Figure 2. An example of the cases. IVUS-guided DCA 6 adjunctive PTCA (IVUS images of pre-DCA, post-DCA-1, post-DCA-2,
post-PTCA).
Table 1. Patient Demographics
DCA
(n 5 106)
DCA/PTCA
(n 5 108)
p
Value
Mean age (yrs) 62 60 NS
Male 95% 87% 0.034
Diabetes 19% 21% NS
Hyperlipidemia 29% 39% NS
Hypertension 51% 32% 0.004
Prior MI (any) 40% 40% NS
Prior CABG 2% 1% NS
Smoking 63% 54% NS
LVEF 62% 61% NS
Unstable angina 30% 22% NS
CABG 5 coronary artery bypass graft surgery; DCA 5 directional coronary
atherectomy; LVEF 5 left ventricular ejection fraction; MI 5 myocardial infarction;
PTCA 5 percutaneous transluminal coronary angioplasty.
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With three cycles of the DCA treatment, there was a trend
toward more tissue removal and a higher incidence of deep
cuts (either resection of media or adventitia). The final
residual plaque area was similar regardless of the number of
cycles.
Complications. The incidence of complications for each
randomized group is summarized in Table 5. There were no
deaths or coronary bypass surgery in either group. Myocar-
dial infarction was observed in two patients (1.8%) in the
DCA-alone group and one patient (0.9%) in the DCA/
PTCA group. Abrupt occlusion was observed in one patient
in each group, and one patient had extravasation of contrast
after balloon dilation. Overall, there was no difference in the
incidence of complications between the two randomized
groups.
QCA data. The acute and follow-up results of the QCA
data are summarized in Table 6. There was no difference in
the vessel size and preprocedural stenosis. Postprocedural
MLD was significantly larger and the percent DS was
significantly lower for the adjunctive PTCA group com-
pared with the DCA-alone group. Three-month angio-
grams were available in 191 patients (89%), and six-month
angiograms were available in 199 patients (93%). There was
no significant difference in MLD and percent DS between
the two groups at three and six months. Cumulative QCA
curves are shown in Figure 3. Loss index was similar in both
groups: 51.3% for DCA alone and 55.6% for adjunctive
PTCA. The six-month angiographic binary restenosis was
defined as .50% stenosis at six months or sooner, including
patients who underwent target vessel revascularization
within six months. The overall restenosis rate of this study
was 21.4%. The restenosis rate for the DCA alone group
was 19.6% and 23.6% for the DCA/PTCA group, resulting
in no significant difference between the two groups.
QCU data. The acute results of the QCU data are sum-
marized in Table 7. Postprocedural MLD, vessel area and
lumen area were all significantly larger for the adjunctive
PTCA group compared with the DCA-alone group, while
all the parameters were not different between the groups
before the procedure and also before adjunctive PTCA.
Postprocedure plaque burden was low in both groups but
significantly lower in the DCA/PTCA group (DCA alone,
45.6% vs. DCA/PTCA, 42.6%).
Clinical outcome. Six-month clinical follow-up was avail-
able in 212 patients (99%) with a mean follow-up period of
Table 3. DCA Procedures
DCA Alone
(n 5 106)
DCA/PTCA
(n 5 108) p Value
Final DCA catheter
EX/SCA 7FG 18% 22% NS
EX 7F 31% 33% NS
GTO 7F 51% 45% NS
DCA-IVUS cycle
1 cycle 65% 58% NS
2 cycles 25% 31% NS
3 cycles 10% 11% NS
No. of cuts 31 32 NS
Cutting pressure 30.5 psi 31.0 psi NS
Tissue weight 17.7 mg 19.1 mg NS
DCA 5 directional coronary atherectomy; IVUS 5 Intravascular ultrasound; PTCA
5 percutaneous transluminal coronary angioplasty.
Table 4. Effect of IVUS on DCA
One Cycle
(n 5 132)
(62%)
Two Cycles
(n 5 59)
(28%)
Greater Than
Three Cycles
(n 5 23)
(10%)
Total no. of cuts 28.8 6 13.4 39.9 6 16.9 42.3 6 14.5
Tissue weight 18.1 mg 16.8 mg 23.1 mg
Intima 44% 46% 26%
Media 38% 38% 53%
Adventitia 18% 16% 21%
Post-MLD (QCU) 3.1 mm 3.1 mm 3.0 mm
Post-DCA PA 8.1 mm2 9.4 mm2 8.2 mm2
Percent PA 45.1% 48.2% 49.1%
MLD 5 minimal luminal diameter; PA 5 plaque area; QCU 5 quantitative coronary
ultrasonography.
Table 5. Acute and In-hospital Complications
DCA
(n 5 106)
DCA/PTCA
(n 5 108)
Death 0 0
CABG 0 0
MI: Q wave 1 (0.9%) 0
Non-Q wave 1 (0.9%) 1 (0.9%)
Abrupt closure 1 (0.9%) 1 (0.9%)
Extravasation 0 1 (0.9%)
Groin pseudoaneurysm
(Surgical repair required)
0 1 (0.9%)
Abbreviations as in Table 1.
Table 2. Lesion Characteristics
DCA
(n 5 106)
DCA/PTCA
(n 5 108) p Value
De novo lesion 78.3% 79.6% NS
Target vessel
RCA 23% 38% NS
LAD 63% 54% NS
LCX 14% 8% NS
ACC/AHA lesion type
Type A 17.9% 21.3% NS
Type B1 56.6% 48.1% NS
Type B2 25.5% 30.6% NS
Type C 0% 0% NS
DCA 5 directional coronary atherectomy; LAD 5 left arterior decending coronary
artery; LCX 5 left circumflex coronary artery; PTCA 5 percutaneous transluminal
coronary angioplasty; RCA 5 right coronary artery.
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6.9 6 1.2 months. In addition, 12-month clinical follow-up
was available in 210 patients (98%). The clinical cumulative
events, including acute procedural events, are summarized
in Table 8. At six months, there were no cardiac deaths in
either group. Major adverse cardiac event rates (cardiac
death, Q wave MI, CABG, target lesion revascularization
[TLR]), including in-hospital events, were 17.1% for DCA
alone and 20.6% for DCA with adjunctive PTCA (p 5
NS). Although the rate for TLR was slightly higher in the
DCA with adjunctive PTCA group (15.2% for DCA alone
and 20.6% for DCA with adjunctive PTCA), the difference
was not statistically significant. At 12 months, there were no
cardiac deaths in either group. The requirement for TLR after
six months was rare (none for the DCA alone group and only
one patient in the DCA with adjunctive PTCA group).
DISCUSSION
This study demonstrated two important DCA outcomes.
The first was that careful and aggressive DCA using IVUS
information by experienced operators provided excellent
acute results with not only low residual stenosis by angio-
gram but also low residual plaque mass by IVUS without an
increased risk of complications. These initial optimal results
were associated with a low incidence of restenosis at six
months. The second was that adjunctive PTCA after
aggressive DCA further improved lumen size without in-
creasing the risk of complications; however, there was no
improvement in either angiographic or clinical outcome at
six months compared with the DCA-alone group.
Effects of adjunctive PTCA. Previous studies (OARS,
BOAT) (3,4) have demonstrated that adjunctive PTCA
after angiographically optimal DCA further increased
MLD and decreased residual percent DS. Because postin-
terventional lumen size is the most important predictor for
restenosis described by Kuntz et al. (6) and by subsequent
studies, improvement of the lumen size with adjunctive
PTCA after optimal DCA may improve long-term out-
come. Based on this information, most patients were treated
with adjunctive PTCA after DCA.
In this randomized study, the effect of adjunctive PTCA
was evaluated. Adjunctive PTCA further improved lesion
lumen size despite more aggressive initial DCA without an
increased risk of complications, as expected from other
previous studies. However, there were no significant differ-
ences in MLD and percent DS or restenosis rate at six
months. The reasons for the deviation from previously
described large lumen concept are not clear and could be
multifactorial. The improvement by adjunctive PTCA after
IVUS-guided DCA is relatively small and may not be
significant enough to sustain the initial benefit at six
months. Also, adjunctive PTCA after aggressive DCA may
increase the tissue response with neointimal hyperplasia and
Figure 3. Cumulative distribution of MLD by QCA. Preinterven-
tion, postintervention and six-month follow-up.
Table 6. QCA Analysis
DCA
(n 5 106)
DCA/PTCA
(n 5 108)
p
Value
Reference diameter 3.24 6 0.55 3.21 6 0.61 NS
MLD (mm)
Pre 1.04 6 0.44 1.03 6 0.34 NS
Post 2.60 6 0.51 2.88 6 0.48 0.006
3 months 1.94 6 0.63 2.05 6 0.59 NS
6 months 1.80 6 0.51 1.85 6 0.61 NS
% DS
Pre 68.7 6 12.7 68.0 6 10.6 NS
Post 15.0 6 10.0 10.8 6 10.0 0.009
3 months 29.7 6 17.8 26.6 6 19.1 NS
6 months 32.3 6 15.9 33.4 6 19.9 NS
Restenosis rate 19.6% 23.6% NS
Loss index 54.2 6 57.0 53.3 6 37.1 NS
DCA 5 directional coronary atherectomy; MLD 5 minimal luminal diameter; %DS
5 percent diameter stenosis; PTCA 5 percutaneous transluminal coronary angio-
plasty.
Table 7. QCU Analysis
DCA
(n 5 106)
DCA/PTCA
(n 5 108)
p
Value
MLD (mm)
Pre 1.95 6 0.44 1.94 6 0.42 NS
Post-DCA 3.04 6 0.50 3.06 6 0.49 NS
Final 3.04 6 0.50 3.26 6 0.48 , 0.001
Vessel area (mm2)
Pre 16.39 6 4.92 16.64 6 4.68 NS
Post-DCA 17.65 6 5.09 18.38 6 4.70 NS
Final 17.65 6 5.09 18.85 6 4.53 0.04
Lumen area (mm2)
Pre 4.08 6 1.63 4.09 6 1.60 NS
Post-DCA 9.44 6 3.13 9.57 6 2.59 NS
Final 9.44 6 3.13 10.64 6 2.59 , 0.001
Percent plaque area
Pre 74.36 6 8.73 74.83 6 8.61 NS
Post-DCA 45.56 6 11.89 47.02 6 11.33 NS
Final 45.56 6 11.89 42.58 6 10.35 , 0.001
DCA 5 directional coronary atherectomy; MLD 5 minimal luminal diameter;
PTCA 5 percutaneous transluminal coronary angioplasty.
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enhance the process of remodeling of the vessel wall, or may
improve the lumen size only temporarily. This randomized
study clearly demonstrated that adjunctive PTCA is not
necessary when adequate results are obtained with IVUS-
guided DCA.
IVUS-guided DCA. DCA is performed under angio-
graphic guidance. As demonstrated in BOAT, this ap-
proach provides angiographically optimal DCA without a
significant risk of perforation, however, to achieve more
effective debulking, IVUS may be necessary to guide more
precise DCA (5,7,8). It had been demonstrated that angio-
grams often mislead the distribution of plaque, and IVUS is
the only currently available method to evaluate plaque
distribution and extensiveness of the disease accurately. In
this study, IVUS was used to select appropriate cases and to
guide the DCA procedure. Based on IVUS findings, ap-
propriately sized devices were selected. Many cases were
performed with larger balloon devices (7 F graft devices),
much higher than used in the OARS trial. The device
window orientation was based on IVUS findings; the plaque
orientation was determined by the relationship between
plaque and side branches, and window orientation was
guided by the relative relationship with the side branch.
After initial DCA with optimal angiographic results, IVUS
was repeated to evaluate the effectiveness of debulking.
When the debulking was inadequate by IVUS findings,
despite optimal angiographic results, more aggressive DCA
with higher balloon pressures, larger devices and multiple
cuts were attempted. More than one-third of patients were
treated with two or more cycles of the DCA procedure
based on post-DCA IVUS findings. In the OARS trial, in
which IVUS was used in all cases, post-DCA IVUS was
obtained mostly to evaluate the DCA results and not
necessarily to guide more aggressive subsequent DCA. In
this study, the most remarkable finding is the low residual
plaque mass after DCA; residual plaque mass was only
42.6%. In OARS, despite better angiographic results (residual
stenosis OARS 7%, ABACAS 13%), the residual plaque mass
by IVUS was 58%, much higher than ABACAS.
The one major concern of aggressive DCA, particularly
under angiographic guidance alone, is perforation (9). Al-
though the incidence is low, obviously perforation needs to
be prevented because of potentially significant clinical
events. In this study, aggressive DCA guided by IVUS was
safe without significantly increasing the risk of perforation;
clinically nonsignificant contrast extravasation without tam-
ponade was observed in 0.5%. Meticulous and precise
orientation of the window of the device towards the plaque
probably prevented clinically significant perforations; how-
ever, histologic evaluation demonstrated a high incidence of
deep cuts (either excision of media or adventitia). These
deep cuts may be difficult to avoid with current approaches
because of sequential use of IVUS and the orientation of the
window are not as precise as needed to avoid deep cuts.
Although clinical significance of “deep cuts” remained contro-
versial (10–12), cutting adventitia needs to be avoided to
prevent perforation and late pseudoaneurysm formation (13).
In this study, it was demonstrated that adequate debulk-
ing can be achieved by IVUS-guided DCA; however, there
are certain limitations with the current approach. One of the
most significant limitations is that information by IVUS is
sequential and not simultaneous. Although plaque distribu-
tion can be determined by the relationship to side branches,
particularly in the left anterior descending artery using a
diagonal branch or septal, the window orientation relative to
plaque distribution is still limited with less accuracy. To
achieve more effective debulking or to avoid deep cuts,
simultaneous IVUS image capability during the cutting
process is required. One of the other major limitations is
that the procedure becomes much more complex and time
consuming. To evaluate with IVUS frequently during the
DCA procedure may not be practical in most of the busy
interventional practices for routine use.
Table 8. Cumulative Clinical Events
6 Months 12 Months
DCA Alone
(n 5 105)
DCA/PTCA
(n 5 107)
DCA Alone
(n 5 105)
DCA/PTCA
(n 5 105)
MACE 18 (17.1%) 22 (20.6%) 19 (18.1%) 23 (21.9%)
Death
Cardiac 0 0 0 0
Noncardiac 0 1 (0.9%) 0 2 (1.9%)
MI
Q MI 1 (0.9%) 0 1 (0.9%) 0
non-Q MI 2 (1.9%) 1 (0.9%) 3 (2.8%) 1 (0.9%)
CABG 0 1 (0.9%) 0 1 (0.9%)
Stroke 0 1 (0.9%) 0 3 (2.8%)
TLR 16 (15.2%) 22 (20.6%) p 5 0.361 16 (15.2%) 23 (21.9%)
CABG 5 coronary artery bypass graft surgery; DCA 5 directional coronary atherectomy; MACE 5 cardiac death/Q-MI/
CABG/TLR, including acute adverse events; MI 5 myocardial infarction; PTCA 5 percutaneous transluminal coronary
angioplasty; TLR 5 target lesion revascularization.
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Restenosis. The restenosis rate after IVUS-guided DCA
in this study was one of the lowest rates among published
data in the past. In OARS, the restenosis rate was 30%,
higher than ABACAS, despite slightly better angiographic
results (residual stenosis 7% in OARS, 13% in ABACAS).
One of the significant differences in the procedural aspects
of these two studies is the residual plaque mass after
angiographically optimal DCA; residual plaque mass was
much lower in ABACAS (45.6% for DCA alone and 42.6%
for DCA with adjunctive PTCA) compared with OARS
(58.5%). Figure 4 shows the relationship between angio-
graphic residual stenosis and restenosis rate of previously
published DCA trials. In ABACAS, the restenosis rate
seems to be discordant compared with other studies. These
findings are also somewhat different from previously pub-
lished data of “large lumen” concept, in which final MLD is
the most important prognostic factor. Some previous studies
have demonstrated that plaque burden is one of the signif-
icant predictors for restenosis after intervention (14). The
low restenosis rate in ABACAS may be due to the low
residual plaque burden compared with previous other stud-
ies. Optimal debulking may be important to reduce the
restenosis rate. Comparison of ABACAS data to others
needs to be careful and in perspective, because these studies
were done in a different set, with different operators and
were not designed to compare with other studies. In this
study, the mechanism of restenosis was not studied, and it is
not clear what is the effect of plaque burden on the
restenosis process. Plaque burden may influence the process
of remodeling of the artery and intimal hyperplasia, as
shown in some of the previous studies with IVUS analysis
(15–19). In this study, some patients had follow-up IVUS
studies, and analysis of these data in the future may provide
some insights into the restenosis process.
Conclusion. With IVUS guidance, aggressive DCA
yielded effective debulking with low residual plaque mass
without increasing the risk of complications. This aggressive
DCA was associated with a low angiographic restenosis
rate. After aggressive DCA, adjunctive PTCA further
enlarged lumen size without risk of complication; however,
there was no significant angiographic or clinical benefit
achieved by adjunctive PTCA.
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